Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Graybill

Showing results (11-20 of 205) with videos related to

Pageof 21
Sort By:
International Journal of Clinical Practice|January 5, 2002
The echinocandins, first novel class of antifungals in two decades: will they live up to their promise?J R Graybill
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|September 30, 2000
Changing strategies for treatment of systemic mycosesJ R Graybill
Seminars in Oncology|July 22, 1998
Itraconazole: managing mycotic complications in immunocompromised patientsJ R Graybill
Advances in Neurology|January 1, 1974
Transfer factor in diseases of the central nervous systemJ R Graybill
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1992
Future directions of antifungal chemotherapyJ R Graybill
Infectious Disease Clinics of North America|December 1, 1988
Systemic fungal infections: diagnosis and treatment. I. Therapeutic agentsJ R Graybill
Annals of the New York Academy of Sciences|January 1, 1988
Treatment of coccidioidomycosisJ R Graybill
Seminars in Respiratory Infections|March 1, 1986
Azole antifungal drugs in treatment of coccidioidomycosisJ R Graybill
The Journal of Infection|May 1, 1994
Is there a correlation between serum antifungal drug concentration and clinical outcome?J R Graybill
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|August 10, 2000
Prevention of systemic mycoses in patients who are not neutropenic: should we do it? Can we do it?J R Graybill
Pageof 21

Showing results (11-20 of 205) with videos related to

Sort By:
Pageof 21
International Journal of Clinical Practice|January 5, 2002
The echinocandins, first novel class of antifungals in two decades: will they live up to their promise?J R Graybill
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|September 30, 2000
Changing strategies for treatment of systemic mycosesJ R Graybill
Seminars in Oncology|July 22, 1998
Itraconazole: managing mycotic complications in immunocompromised patientsJ R Graybill
Advances in Neurology|January 1, 1974
Transfer factor in diseases of the central nervous systemJ R Graybill
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1992
Future directions of antifungal chemotherapyJ R Graybill
Infectious Disease Clinics of North America|December 1, 1988
Systemic fungal infections: diagnosis and treatment. I. Therapeutic agentsJ R Graybill
Annals of the New York Academy of Sciences|January 1, 1988
Treatment of coccidioidomycosisJ R Graybill
Seminars in Respiratory Infections|March 1, 1986
Azole antifungal drugs in treatment of coccidioidomycosisJ R Graybill
The Journal of Infection|May 1, 1994
Is there a correlation between serum antifungal drug concentration and clinical outcome?J R Graybill
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|August 10, 2000
Prevention of systemic mycoses in patients who are not neutropenic: should we do it? Can we do it?J R Graybill
Pageof 21